Cathie Wood Keeps Buying Rocket Lab Stock as It Trades at Less Than Half Its Record

ARK Invest bought nearly 1.3 million Rocket Lab shares for more than $85 million across three waves from Aug. 31 to Oct. 1, while the stock was about 55% below its late-May high. Rocket Lab reported a record $2.36 billion backlog as of June 30, up 137% year over year, but Neutron’s first-flight timing remains uncertain and Q2 free cash flow was negative $110 million. Cash and securities totaled about $2.36 billion at June 30, with a further $1.94 billion raised through share sales by mid-September; the article argues dilution and a valuation near 44 times guided annualized sales leave limited room for execution delays.

Analysis

The market is underwriting more than demand: it is underwriting Neutron qualification, repeatable flight cadence and attractive economics. A full manifest is not equivalent to near-term revenue or cash conversion when delivery depends on a rocket that has not flown; verify cancellation terms, customer deposits and expected contribution economics before treating backlog as downside protection. With equity issuance already part of the funding mix, schedule slips can compound dilution even while liquidity remains ample.

The second-order beneficiary of a Neutron delay is not just a rival launch provider: customers seeking independent access to orbit may defer constellation deployment or pay more for scarce slots, while providers with proven vehicles gain negotiating leverage. Conversely, a reliable Neutron would improve customer bargaining power and reduce U.S. launch concentration. Iridium’s exposure is transaction-specific; without deal terms and closing conditions, do not infer whether the pending acquisition is accretive or a catalyst for IRDM.

Near term, qualification-test results and any change to the first-flight window matter more than incremental bookings. Over 6–18 months, flight cadence, cash burn and additional equity issuance determine whether backlog translates into per-share value. The contrarian risk to the bearish framing is that scarce launch capacity could make long-dated contracts strategically valuable before Neutron flies; however, the current valuation leaves limited room for execution disappointment. Thesis improves with successful qualification/flight and narrowing cash burn; it weakens materially with a schedule reset, worsening burn or renewed dilution.

Key Decisions for Investors

• RKLB: avoid adding on backlog announcements alone. Reassess after qualification-test results and the first flight; require evidence of cadence and cash conversion before paying for the long-dated capacity thesis.
• For a tactical bearish expression, consider a defined-risk RKLB put spread only if implied volatility and spread pricing are reasonable, preferably around a confirmed schedule slip rather than ahead of a binary test. Risk is a successful test or launch-driven squeeze; invalidate on on-time execution plus improving burn.
• Monitor quarterly backlog conversion, customer advances/cancellation terms, cash burn and share count. These are the missing measures needed to distinguish contracted demand from funded, profitable delivery.
• No standalone IRDM trade from this article: the transaction’s price, financing structure and closing conditions are not provided. Revisit only when terms or regulatory milestones clarify the effect on Iridium shareholders.